Japan Grants Orphan Drug Designation to Eisai’s Novel Orexin Agonist for Narcolepsy
E2086, a selective orexin 2 receptor agonist, aims to address the pathophysiology of narcolepsy by activating orexinergic neurons.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
